Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 5 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 2 days agoROCK HILL, S.C. - Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from...
COVID-19 Virus Can Lurk in Sperm for 100+ Days After Infection
SciTechDaily· 2 days agoSARS-CoV-2 was detected in male reproductive cells under the microscope even when PCR testing failed...
Opinion | Why the Pandemic Probably Started in a Lab, in 5 Key Points
New York Times· 6 days agoDr. Chan is a molecular biologist at the Broad Institute of M.I.T. and Harvard, and a co-author of...
Will FLiRT COVID variants bring another summer surge? What to know about symptoms and potential for...
Fortune via Yahoo Finance· 4 days ago“The mutations will keep happening.” The Omicron variant of SARS-CoV-2, the coronavirus that causes...
N95 respirator gets top billing in stopping SARS-CoV-2 viral leakage into the air
Center for Infectious Disease Research and Policy· 5 days agoResearchers who compared the ability of cloth and surgical masks and KN95 and N95 respirators to...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 3 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required SARS-...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 2 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 2 days agoIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoAccording to the panel, vaccine manufacturers should design updated vaccines to target the JN.1...